Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing adoption of single-use bioprocessing systems
3.2.1.2 Rising implementation of process analytical technology (PAT)
3.2.1.3 Increasing demand for biopharmaceuticals
3.2.2 Industry pitfalls & challenges
3.2.2.1 High capital costs
3.2.2.2 Technical and operational challenges related to upstream bioprocessing
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Bioreactors/Fermenters
5.3 Cell culture products
5.4 Filters
5.5 Bioreactor accessories
5.6 Bags & containers
5.7 Other products
Chapter 6 Market Estimates and Forecast, By Usage Mode, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Multi-use
6.3 Single-use
Chapter 7 Market Estimates and Forecast, By Mode, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 In-house
7.3 Outsourced
Chapter 8 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Monoclonal antibody production
8.3 Vaccine production
8.4 Cell and gene therapy production
8.5 Other applications
Chapter 9 Market Estimates and Forecast, By End-User, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Biopharmaceutical companies
9.3 CDMOs and CROs
9.4 Research and academic institutes
Chapter 10 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Applikon Biotechnology
11.2 Boehringer Ingelheim GmbH
11.3 CellGenix GmbH
11.4 Corning, Inc.
11.5 Danaher Corporation (Cytvia)
11.6 Eppendorf AG
11.7 Merck KGaA
11.8 PBS Biotech, Inc.
11.9 Sartorius AG
11.10 Thermo Fisher Scientific Inc.
